Suchergebnisse - "Amandeep Salhotra"

1

Role of Radiation Based Conditioning Regimens in Patients With High-Risk AML Undergoing Allogenic Transplantation in Remission or Active Disease and Mechanisms of Post-Transplant Relapse

von: Amandeep Salhotra

2022, in: Frontiers in Oncology

Wird geladen...
2

Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy

von: Colton Ladbury

2022, in: Frontiers in Oncology

Wird geladen...
3

Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience review

von: Jeffrey Y.C. Wong

2022, in: Frontiers in Oncology

Wird geladen...
4

Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia

von: Colton Ladbury

2022, in: Frontiers in Oncology

Wird geladen...
5

Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes

von: Ibrahim Aldoss

2021, in: Blood Cancer Journal

Wird geladen...
6

Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice

von: Ji Eun Lim

2022, in: Frontiers in Oncology

Wird geladen...
7

Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study

von: Corinna La Rosa

2023, in: Frontiers in Immunology

Wird geladen...
8

Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy

von: Flavia Chiuppesi

2023, in: Vaccines

Wird geladen...
9

Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐CBFit)

von: Celalettin Ustun

2018, in: Cancer Medicine

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!